Steven Quay
President and CEO
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Chief Executive Officer | $730,961 | $2,502,856 |
| 2024 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Executive Officer | $705,910 | $2,764,082 |
| 2023 | Atossa Therapeutics, Inc. (ATOS) | M.D., Ph. D. Executive Officer | $705,910 | $2,356,220 |
| 2022 | Atossa Therapeutics, Inc. (ATOS) | M.D. Ph. D. Executive Officer | $705,910 | $3,160,876 |
| 2021 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. Executive Officer | $659,000 | $5,892,563 |
| 2020 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. Executive Officer | $600,624 | $2,936,284 |
| 2019 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. President and Chief Executive Officer | $600,624 | $5,807,923 |
| 2018 | Atossa Therapeutics, Inc. (ATOS) | MD., Ph.D. President and Chief Executive Officer | $582,000 | $2,172,344 |
Earnings-call appearances
-
Atossa Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-14
Atossa Therapeutics, Inc. (ATOS)